Non-Nucleoside Reverse Transcriptase Inhibitors: The NNRTI Boom-Reference-Cited by-同舟云学术

Non-Nucleoside Reverse Transcriptase Inhibitors: The NNRTI Boom

Published:1999-12 Issue:6 Volume:10 Page:285-314
ISSN:2040-2066
Container-title:Antiviral Chemistry and Chemotherapy
language:en
Short-container-title:Antivir Chem Chemother

Author:

Pedersen Ole S¹,Pedersen Erik B¹

Affiliation:

1. Department of Chemistry, University of Southern Denmark, Odense University, DK-5230 Odense M, Denmark

Abstract

Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are promising drugs for the treatment of HIV when used in combination with other anti-HIV drugs such as nucleoside reverse transcriptase (RT) inhibitors and protease inhibitors. The first generation of NNRTIs have, however, suffered from the rapid development of resistance. This review discusses the properties of the FDA-approved NNRTI drugs and focuses on the recent efforts being made to produce second generation inhibitors that circumvent this resistance problem.

Publisher

SAGE Publications

Link

http://journals.sagepub.com/doi/pdf/10.1177/095632029901000601

Reference104 articles.

1. The PETT series, a new class of potent nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase

2. The quinoline U-78036 is a potent inhibitor of HIV-1 reverse transcriptase

3. The benzylthio-pyrimidine U-31,355, a potent inhibitor of HIV-1 reverse transcriptase

4. Novel 1,1,3-Trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazine Derivatives as Non-Nucleoside Reverse Transcriptase Inhibitors That Inhibit Human Immunodeficiency Virus Type 1 Replication

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nucleoside and non-nucleoside reverse transcriptase inhibitor drugs (NRTIs and NNRTIs) are capable of binding Chandipura virus polymerase protein (L) and inhibit virus replication;VirusDisease;2024-07-08

2. Synthesis, in vitro Anti-HIV-1RT evaluation, molecular modeling, DFT and acute oral toxicity studies of some benzotriazole derivatives;Journal of Structural Biology;2024-06

3. Mathematical model of replication-mutation dynamics in coronaviruses;2024-01-29

4. Identification of a Non-Nucleoside Reverse Transcriptase Inhibitor against Human Immunodeficiency Virus-1;ACS Infectious Diseases;2023-07-07

5. Design, cross-docking and ONIOM studies of potent antiviral HIV-1 nonnucleoside reverse transcriptase inhibitors;2023-05-15